In Response
- PMID: 36585746
- PMCID: PMC10026950
- DOI: 10.1097/ICL.0000000000000969
In Response
Conflict of interest statement
The authors have no conflicts of interest to disclose.
References
-
- Richdale K, Tomiyama ES, Novack GD, et al. . Compounding of low concentration atropine for myopia control. Eye & Contact Lens 2022;48:489–492. - PubMed
-
- Therapeutic Goods Administration (TGA) Australian Register of Therapeutic Goods (ARTG). EIKANCE 0.01% atropine sulfate monohydrate 100 microgram/1mL eye drops solution packed in single-dose ampoules (331960). Australian product information. (Eikance 0.01% eye drops (atropine sulfate monohydrate) sterile ophthalmic solution). Available at: https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&.... Accessed December 27, 2022.
-
- Yam JC, Jiang Y, Tang SM, et al. . Low-concentration atropine for myopia progression (LAMP) study: A randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025% and 0.01% atropine eye drops in myopia control. Ophthalmology 2019;126:113–124. - PubMed
LinkOut - more resources
Full Text Sources